We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ADGI market cap is 510.93M. The company's latest EPS is USD -1.8040 and P/E is -1.15.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -47.33M | -30.84M | -39.07M | -53.88M | -43.06M |
| Net Income | -45.09M | -44.57M | -35.32M | -50.23M | -39.44M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -226.91M | -230.66M | -212.76M |
| Net Income | -226.79M | -241.32M | -198.64M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 424.75M | 383.17M | 350.56M | 315.41M | 274.92M |
| Total Liabilities | 47.3M | 27.2M | 23.82M | 33.85M | 28.42M |
| Total Equity | 377.44M | 355.97M | 326.75M | 281.56M | 246.5M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 620.09M | 383.17M | 229.18M |
| Total Liabilities | 62.07M | 27.2M | 51.71M |
| Total Equity | 558.02M | 355.97M | 177.47M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -172.58M | -219.99M | -41.18M | -78.57M | -113.92M |
| Investing | -91.85M | -230.67M | 75.04M | 107.63M | 202.77M |
| Financing | 365k | 506k | 542k | 812k | 904k |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -184.74M | -219.99M | -173.16M |
| Investing | -50.71M | -230.67M | 280.68M |
| Financing | 662.68M | 506k | 1.05M |
| Market Cap | 510.93M |
| Price to Earnings Ratio | -1.15 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.14 |
| Price to Book Ratio | 1.28 |
| Dividend Yield | - |
| Shares Outstanding | 110.12M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.22 (4.64%) |
| Company Name | Adagio Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://invivyd.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
